Alberto Carmona
@albertocarm.bsky.social
Oncologist. GI and neuroendocrine tumors.
Pinned
Alberto Carmona
@albertocarm.bsky.social
· Nov 19
Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study
AbstractIntroduction. The initial SARS-CoV-2 pandemic wave in Spain in 2020 precipitated significant paradigm shifts in gastrointestinal oncology patient m
academic.oup.com
We are pleased to announce the publication of our recent study: "Three-Year Survival Follow-Up of Patients with Gastrointestinal Cancer Treated During the COVID-19 Pandemic in Spain: Data from the PANDORA-TTD20 Study."
academic.oup.com/oncolo/advan...
academic.oup.com/oncolo/advan...
We are pleased to announce the publication of our recent study: "Three-Year Survival Follow-Up of Patients with Gastrointestinal Cancer Treated During the COVID-19 Pandemic in Spain: Data from the PANDORA-TTD20 Study."
academic.oup.com/oncolo/advan...
academic.oup.com/oncolo/advan...
Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study
AbstractIntroduction. The initial SARS-CoV-2 pandemic wave in Spain in 2020 precipitated significant paradigm shifts in gastrointestinal oncology patient m
academic.oup.com
November 19, 2024 at 7:19 AM
We are pleased to announce the publication of our recent study: "Three-Year Survival Follow-Up of Patients with Gastrointestinal Cancer Treated During the COVID-19 Pandemic in Spain: Data from the PANDORA-TTD20 Study."
academic.oup.com/oncolo/advan...
academic.oup.com/oncolo/advan...